Literature DB >> 27017998

Heads Or Tails: Betting On CD6 As a Resurged Target For Autoimmune Diseases and Sepsis.

Alexandre M Carmo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27017998     DOI： 10.2174/138945011706160324153314

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN： 1389-4501            Impact factor:   3.465


× No keyword cloud information.
  2 in total

1.  Response: Commentary: The Scavenger Receptor SSc5D Physically Interacts with Bacteria through the SRCR-Containing N-Terminal Domain.

Authors:  Liliana Oliveira; Alexandre M Carmo
Journal:  Front Immunol       Date:  2017-08-23       Impact factor: 7.561

2.  T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.

Authors:  Usha Bughani; Arindam Saha; Anshu Kuriakose; Reshmi Nair; Ravindra B Sadashivarao; Rasika Venkataraman; Swati Patel; Anuja Tushar Deshchougule; Satish Kumar S; Enrique Montero; Harish V Pai; Dinesh V Palanivelu; Ramakrishnan Melarkode; Pradip Nair
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.